Identification of Antiviral Phytocompounds as Potential Anti‐Dengue Agents against DENV NS2B/NS3 Protease: An Integrated Molecular Modelling and Dynamics Approach
Sthitaprajna Sahoo,Priyanka Purohit,Subhashish Samantaray,Biswa Ranjan Meher
DOI: https://doi.org/10.1002/slct.202400384
2024-03-20
ChemistrySelect
Abstract:The current study identifies five phytocompounds from eight medicinal plants that have inhibition activity against DENV NS2B/NS3 protease. These five compounds are further investigated through molecular docking followed by a 100 ns MD simulation. Different MD analyses like structural stability analysis, PCA, FEL, DCCM, and MM‐PBSA suggested that these five compounds, particularly Epicatechin (−154.415 kJ/mol) and Quercetin‐3,4′‐Dimethylether (−151.154 kJ/mol) can be studied extensively to develop anti‐dengue therapeutics against this virus. Dengue fever is one of the most dreaded viral diseases caused by the bite of female Aedes aegypti and Aedes albopictus mosquitoes infected with the Dengue virus (DENV). No DENV antiviral drugs have been approved, yet they are desperately needed. The current study focuses on finding potential therapeutics from 8 medicinal plants reported to have activity against the DENV NS2B/NS3 protease in vitro. Eighty‐two phytocompounds were selected from eight different medicinal plants like Vernonia cinerea, Tridax procumbens, Cassia angustifolia, Lawsonia inermis, Dryobalanops aromatic, Punica granatum, Zingiber zerumbet and Zizyphus‐jujuba. The top five phytocompounds (Epicatechin (EPI), Chrysoeriol (CHR), Apigenin (API), Quercetin‐3,4′‐Dimethylether (QUE), and Caffeic acid (CAF)) identified from toxicity evaluation and docking studies were further subjected to 100 ns long Molecular Dynamics (MD) simulations to study their structural stability and binding affinity through MM‐PBSA based free‐energy calculations. MD results revealed overall conformational stability with all the five phytocompounds. Furthermore, MM‐PBSA results suggest binding free energy values of −154.415 kJ/mol, −151.154 kJ/mol, −139.048 kJ/mol, −122.827 kJ/mol), and −120.622 kJ/mol for compound EPI, QUE, API, CAF, and CHR respectively by interacting with essential binding site residues. These compounds could thus be studied extensively to develop nature‐based therapeutic compounds as anti‐dengue agents for DENV2.
chemistry, multidisciplinary